Abstract
Background The behavioural and emotional profiles underlying adolescent self-harm, and its developmental risk factors, are relatively unknown. We aimed to identify sub-groups of young people who self-harm (YPSH) and longitudinal predictors leading to self-harm.
Methods Participants were from the Millennium Cohort Study (n=10,827). A clustering algorithm identified sub-groups who self-harmed with different behavioural and emotional profiles at age 14. Feature selection analyses were then used to identify longitudinal predictors of self-harming behaviour.
Findings There were two distinct sub-groups at age 14: a smaller group (n = 379) who reported a long history of psychopathology, and a second group (n = 905) without. Notably, both groups could be predicted almost a decade before the reported self-harm. They were similarly characterised by sleep problems and low self-esteem, but there was developmental differentiation. From an early age, the first group had poorer emotion regulation, were bullied, and their caregivers faced emotional challenges. The second group showed less consistency in early childhood, but later reported more willingness to take risks and less security with peers/family.
Interpretation Our results uncover two distinct pathways to self-harm: a ‘psychopathology’ pathway, associated with early and persistent emotional difficulties and bullying; and an ‘adolescent risky behaviour’ pathway, where risk-taking and external challenges emerge later into adolescence and predict self-harm. These two pathways have long developmental histories, providing an extended window for interventions as well as potential improvements in the identification of children at risk, biopsychosocial causes, and treatment or prevention of self-harm.
Funding This study was supported by the UK Medical Research Council, Templeton World Charitable Foundation, and a Gates Cambridge Scholarship awarded to SU.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
SU was supported by the Gates Cambridge Trust. ESD and DEA are supported by grant TWCF0159 from the Templeton World Charity Foundation to DEA. SU, RS, and DEA are supported by the UK Medical Research Council, grant MC-A0606-5PQ41. We are grateful to the Centre for Longitudinal Studies (CLS), UCL Institute of Education, for the use of these data and to the UK Data Service for making them available. However, neither CLS nor the UK Data Service bear any responsibility for the analysis or interpretation of these data.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
We received permission and access to the open source data of the Millennium Cohort Study, provided by the UK Data Service and the Centre for Longitudinal Studies (CLS), UCL Institute of Education.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The data is made available by the UK Data Service